Summary & Overview
HCPCS G8860: Prolonged Corticosteroid Exposure ≥10 mg/day for ≥60 Days
HCPCS Level II code G8860 denotes patients who received systemic corticosteroids at doses ≥10 mg/day for at least 60 consecutive days. This code captures sustained corticosteroid exposure that is clinically relevant for monitoring adverse effects, coordinating care across specialties, and informing quality measurement tied to chronic immunosuppressive therapy. Nationally, tracking prolonged steroid use supports safety surveillance and care management for conditions commonly treated with long-term corticosteroids, including autoimmune and inflammatory diseases.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical meaning, typical service settings, and the implications for documentation and claims reporting. The publication outlines benchmarks and reporting contexts where G8860 is used, summarizes relevant policy considerations affecting coverage and quality programs, and situates the code within clinical workflows for medication monitoring. Data not available in the input is noted where applicable; the focus remains on operational and clinical context for national stakeholders involved in coding, quality measurement, and care coordination.
Billing Code Overview
HCPCS Level II code G8860 identifies patients who have received a dose of corticosteroids greater than or equal to 10 mg/day for 60 or greater consecutive days. This measure documents prolonged systemic corticosteroid exposure and is used to capture clinical status related to long-term steroid therapy.
-
Service type: Clinical chronic medication monitoring and management
-
Typical site of service: Outpatient clinics, specialty practices (e.g., rheumatology, pulmonology, gastroenterology), and other ambulatory care settings where long-term corticosteroid therapy is prescribed and reviewed.
Clinical & Coding Specifications
Clinical Context
A 62-year-old female with long-standing rheumatoid arthritis has been managed with oral prednisone 10–15 mg daily for symptom control. After 14 weeks (≥60 consecutive days) of corticosteroid therapy at doses ≥10 mg/day, her primary care physician documents chronic systemic steroid exposure and refers her for osteoporosis risk assessment and infectious disease immunization review. Typical clinical workflow includes review of medication history, assessment of fracture risk (DEXA order), counseling on steroid-sparing alternatives with the rheumatologist, ordering prophylactic measures (calcium/vitamin D), and ensuring up-to-date pneumococcal and influenza immunizations. Medication reconciliation and documentation that the patient received corticosteroids ≥10 mg/day for ≥60 consecutive days are recorded in the problem list and medication history to support use of billing code G8860.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit addresses issues beyond chronic steroid management during the same encounter |